Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyMaarten J. Titulaer, Josep Dalmau, Lindsey McCracken et al.|The Lancet Neurology|2013Cited by 3.1k
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and modelsJosep Dalmau, Francesc Graus, Thaís Armangué et al.|The Lancet Neurology|2019Cited by 853
Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysisThaís Armangué, Clàudia Fortuny, Marianna Spatola et al.|The Lancet Neurology|2018Cited by 645
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodiesMar Petit‐Pedrol, Josep Dalmau, Thaís Armangué et al.|The Lancet Neurology|2014Cited by 615
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational studyThaís Armangué, María Jiménez‐Legido, Gemma Olivé-Cirera et al.|The Lancet Neurology|2020Cited by 326